Disease Research Trackerfrom CloudDots

Is the science moving in your disease area?

Five independent R&D signals per disease: new publications, clinical trials, NIH grants, patents and preprints. Each month's count is compared with the same month a year earlier, and ranked against every month we hold on record, back to 2000 for publications and clinical trials. Publications and patents are measured as a share of everything the source indexed that month.

Biggest movers by publications as a share of all MeSH-indexed PubMed records vs the same month last year

  1. 1oncologyMultiple Myeloma+28.2%provisional settling
  2. 2rareHuntington's Disease+13.3%provisional settling
  3. 3rareAmyotrophic Lateral Sclerosis (ALS)+12.4%provisional settling
  4. 4oncologyPancreatic Cancer+8.8%provisional settling
  5. 5rareCystic Fibrosis-1.5%provisional settling

Rare disease

rareAmyotrophic Lateral Sclerosis (ALS)
+12.4%publications share vs same month last year
provisional settlingPubs +12%Trials typicalGrants peakPatents peakPreprints typicalrareCystic Fibrosis
-1.5%publications share vs same month last year
provisional settlingPubs -1%Trials lowGrants peakPatents typicalPreprints typicalrareDuchenne Muscular Dystrophy
-9.5%publications share vs same month last year
provisional settlingPubs -9%Trials typicalGrants highPatents peakPreprints highrareHuntington's Disease
+13.3%publications share vs same month last year
provisional settlingPubs +13%Trials lowGrants highPatents peakPreprints high

Metabolic

metabolicMASH / NASH
-8.3%publications share vs same month last year
provisional settlingPubs -8%Trials +42%Grants highPatents highPreprints lowmetabolicObesity
-3.5%publications share vs same month last year
provisional settlingPubs -3%Trials +24%Grants highPatents highPreprints typical

Oncology

oncologyGlioblastoma
-10.0%publications share vs same month last year
provisional settlingPubs -10%Trials peakGrants peakPatents peakPreprints highoncologyMultiple Myeloma
+28.2%publications share vs same month last year
provisional settlingPubs +28%Trials +5%Grants highPatents highPreprints typicaloncologyNon-Small-Cell Lung Cancer
-5.5%publications share vs same month last year
provisional settlingPubs -5%Trials -16%Grants highPatents peakPreprints typicaloncologyPancreatic Cancer
+8.8%publications share vs same month last year
provisional settlingPubs +9%Trials -40%Grants highPatents peakPreprints typical

How it works

Each disease page tracks five signals. Each month's count is compared with the same month a year earlier. Publications are counted as a share of the PubMed records given MeSH headings that month, and patents as a share of all US pre-grant applications published that month. Where both months are under 15 records, or a signal has fewer than 24 months of history, the page shows where the reading sits in its own history instead of a percentage. The term mappings (PubMed MeSH heading, OpenAlex topics, ClinicalTrials.gov conditions, patent CPC) are published on each page.